GSP Crop Science’s Rs 400 crore IPO opens on March 16. Check price band, other key details – News Air Insight

Spread the love


GSP Crop Science Limited has fixed the price band for its Rs 400 crore initial public offering at Rs 304 to Rs 320 per equity share. The company’s IPO will open for subscription on Monday, March 16, 2026, and close on Wednesday, March 18, 2026.

The IPO is a book built issue of Rs 400 crore, comprising a fresh issue of 0.75 crore shares worth Rs 240 crore and an offer for sale of 0.50 crore shares aggregating to Rs 160 crore. The offer for sale will be undertaken by promoters Vilasben Vrajmohan Shah, Bhavesh Vrajmohan Shah and Kappa Trust.

Investors can bid for a minimum of 46 equity shares and in multiples of 46 shares thereafter. The company currently has 39,018,750 outstanding equity shares of face value Rs 10 each.

The company plans to use Rs 170 crore from the fresh issue towards repayment or prepayment of certain outstanding borrowings, while the remaining proceeds will be used for general corporate purposes.

GSP Crop Science is a research driven agrochemical company engaged in the development and manufacturing of insecticides, herbicides, fungicides and plant growth regulators in India. The company has over 40 years of experience in the agrochemical industry and provides crop protection solutions aimed at helping farmers improve productivity and agricultural output.


As of September 30, 2025, the company had received 524 registrations across formulations and technical agrochemicals manufactured by it.

For the six months ended September 30, 2025, the company reported revenue from operations of Rs 844.2 crore and a net profit of Rs 81 crore. For FY25, revenue from operations stood at Rs 1,287.38 crore, compared with Rs 1,203.3 crore in FY23. Net profit for FY25 was Rs 81.4 crore, up from Rs 17.5 crore in FY23.The offer is being made through the book building process, with up to 50% of the net offer reserved for qualified institutional buyers, not more than 15% for non institutional investors, and 35% for retail individual investors.

Equirus Capital Private Limited and Motilal Oswal Investment Advisors Limited are the book running lead managers to the issue, while MUFG Intime India Private Limited is the registrar.

(Disclaimer: Recommendations, suggestions, views and opinions given by the experts are their own. These do not represent the views of The Economic Times)



Source link

Leave a Reply

Your email address will not be published. Required fields are marked *